ARGX:NSD-argenx NV ADR (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 640.14

Change

+1.14 (+0.18)%

Market Cap

USD 40.41B

Volume

0.20M

Analyst Target

USD 254.56
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

+8.57 (+1.82%)

USD 118.90B
ALNY Alnylam Pharmaceuticals Inc

+0.49 (+0.20%)

USD 34.99B
ONC BeiGene, Ltd.

+7.51 (+3.17%)

USD 25.62B
RPRX Royalty Pharma Plc

+0.74 (+2.27%)

USD 18.65B
SMMT Summit Therapeutics PLC

+1.46 (+6.76%)

USD 17.52B
UTHR United Therapeutics Corporatio..

-13.42 (-3.52%)

USD 15.68B
INCY Incyte Corporation

+1.22 (+1.74%)

USD 14.29B
INSM Insmed Inc

-0.22 (-0.26%)

USD 13.70B
MRNA Moderna Inc

-2.17 (-6.04%)

USD 12.93B
BMRN Biomarin Pharmaceutical Inc

+3.12 (+4.76%)

USD 12.08B

ETFs Containing ARGX

SRHE:LSE Amundi Index Solutions - .. 3.35 % 0.00 %

+16.50 (+-0.35%)

USD 0.22B
SRHE:XETRA 3.19 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.77 % 0.00 %

N/A

N/A
HEAL:SW iShares Healthcare Innova.. 2.56 % 0.00 %

+0.01 (+-0.35%)

N/A
STWX:SW SPDR® MSCI Europe Health.. 2.38 % 0.00 %

+0.35 (+-0.35%)

USD 0.69B
SXDPEX:SW iShares STOXX Europe 600 .. 2.25 % 0.00 %

N/A

USD 0.44B
TEET:LSE VanEck Sustainable Europe.. 1.72 % 0.00 %

+0.37 (+-0.35%)

USD 0.05B
TEET:SW 1.36 % 0.00 %

N/A

N/A
TEGB:LSE VanEck Sustainable Europe.. 1.25 % 0.00 %

-0.04 (-0.35%)

N/A
TSGB:LSE VanEck Sustainable World .. 0.67 % 0.00 %

-0.14 (-0.35%)

USD 0.84B
TSWE:SW VanEck Sustainable World .. 0.67 % 0.00 %

-0.12 (-0.35%)

USD 0.84B
AGED:SW iShares Ageing Population.. 0.61 % 0.00 %

+0.01 (+-0.35%)

N/A
TSWE:LSE VanEck Sustainable World .. 0.49 % 0.00 %

+0.04 (+-0.35%)

N/A
BBH VanEck Biotech ETF 0.00 % 0.35 %

+1.08 (+-0.35%)

USD 0.40B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

+0.65 (+-0.35%)

USD 0.06B
FBT First Trust NYSE Arca Bio.. 0.00 % 0.57 %

+0.14 (+-0.35%)

N/A
AGED:LSE iShares Ageing Population.. 0.00 % 0.00 %

N/A

N/A
AGES:LSE iShares IV Public Limited.. 0.00 % 0.00 %

-7.25 (-0.35%)

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

-1.00 (-0.35%)

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+0.04 (+-0.35%)

N/A
HLTH:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

+0.40 (+-0.35%)

N/A
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

+46.00 (+-0.35%)

USD 0.21B
STW:PA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

-0.10 (-0.35%)

USD 0.71B
2B70:F 0.00 % 0.00 %

N/A

N/A
DXSE:F 0.00 % 0.00 %

N/A

N/A
EXV4:F 0.00 % 0.00 %

N/A

N/A
SPYH:F 0.00 % 0.00 %

N/A

N/A
TSWE:F 0.00 % 0.00 %

N/A

N/A
V3ET:F 0.00 % 0.00 %

N/A

N/A
2B70:XETRA 0.00 % 0.00 %

N/A

N/A
2B77:XETRA 0.00 % 0.00 %

N/A

N/A
2B78:XETRA 0.00 % 0.00 %

N/A

N/A
DXSE:XETRA 0.00 % 0.00 %

N/A

N/A
ETLI:XETRA 0.00 % 0.00 %

N/A

N/A
EXV4:XETRA 0.00 % 0.00 %

N/A

N/A
SPYH:XETRA 0.00 % 0.00 %

N/A

N/A
TSWE:XETRA 0.00 % 0.00 %

N/A

N/A
V3ET:XETRA 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

+0.10 (+-0.35%)

USD 3.22M
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

+0.08 (+-0.35%)

USD 0.04B
2B77:F 0.00 % 0.00 %

N/A

N/A
2B78:F 0.00 % 0.00 %

N/A

N/A
ESIH:F 0.00 % 0.00 %

N/A

N/A
ESIH:XETRA 0.00 % 0.00 %

N/A

N/A
HEAE:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

+0.30 (+-0.35%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.09% 66% D+ 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.09% 66% D+ 61% D-
Trailing 12 Months  
Capital Gain 60.06% 86% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.06% 86% B+ 86% B+
Trailing 5 Years  
Capital Gain 297.36% 97% N/A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 297.36% 97% N/A 95% A
Average Annual (5 Year Horizon)  
Capital Gain 24.67% 68% D+ 77% C+
Dividend Return 24.67% 68% D+ 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.52% 87% B+ 63% D
Risk Adjusted Return 83.56% 99% N/A 92% A
Market Capitalization 40.41B 100% F 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector